BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I/II trial to study the effectiveness of combining BMS-247550 with cisplatin in
treating patients who have metastatic or recurrent head and neck cancer. Drugs used in
chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. Combining more than one drug may kill more tumor cells.